Market Cap : 7.18 B | Enterprise Value : 10.07 B | PE Ratio : 26.30 | PB Ratio : 2.16 |
---|
NAS:SYNH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:SYNH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Syneos Health's enterprise value is $10,072 Mil. Syneos Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $685 Mil. Therefore, Syneos Health's EV-to-EBITDA for today is 14.71.
The historical rank and industry rank for Syneos Health's EV-to-EBITDA or its related term are showing as below:
During the past 11 years, the highest EV-to-EBITDA of Syneos Health was 80.28. The lowest was 12.18. And the median was 19.07.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-16), Syneos Health's stock price is $69.99. Syneos Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $2.660. Therefore, Syneos Health's PE Ratio for today is 26.31.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The historical data trend for Syneos Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Syneos Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Syneos Health's EV-to-EBITDA falls into.
Syneos Health's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 10072.160 | / | 684.928 | |
= | 14.71 |
Syneos Health's current Enterprise Value is $10,072 Mil.
Syneos Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $685 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Syneos Health's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 69.99 | / | 2.660 | |
= | 26.31 |
Syneos Health's share price for today is $69.99.
Syneos Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.660.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Syneos Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Zulueta Alfonso G | director | LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
Bodem Barbara W. | director | C/O DENTSPLY SIRONA INC 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 |
Brooks Michael Lee | officer: See remarks | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Wilkes David S. | director | ONE BAXTER PARKWAY DEERFIELD IL 60015 |
Connaughton Bernadette | director | C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139 |
Klitgaard William E | director | 210 CARNEGIE CENTER PRINCETON NJ 08540 |
Meyers Kenneth F | director | 275 NORTH FIELD DRIVE LAKE FOREST IL 60045 |
Monaghan Matthew E. | director | ONE INVACARE WAY ELYRIA OH 44035 |
Harty Linda S | director | MEDTRONIC PLC 710 MEDTRONIC PARKWAY NE, LC-150 MINNEAPOLIS MN 55432 |
Kralowetz Donna Hildebrand | officer: SVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Colvin Paul | officer: Pres., Clinical Solutions | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Parks Robert | officer: EVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Olefson Jonathan | officer: General Counsel & Corp Secty | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Meggs Jason M. | officer: Chief Financial Officer | C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560 |
Gpe Vii Gp S.a.r.l. | 10 percent owner | CO ADVENT INTERNATIONAL 800 BOYLSTON STREET BOSTON MA 02199 |
From GuruFocus
By GlobeNewswire 09-14-2021
By Marketwired 06-03-2021
Other Sources
By Zacks 2021-12-23
By Zacks 2022-02-17
By Zacks 2022-03-18
By Zacks 2021-09-29
By Seekingalpha 2022-02-17
By Zacks 2022-03-23
By Zacks 2021-11-16
By Zacks 2021-08-10
By Zacks 2022-02-10
By Zacks 2021-09-08
By Zacks 2021-08-09
By Zacks 2021-11-03
By Zacks 2022-03-29
By Zacks 2021-09-16